Company Executives Share Vision and Answer Questions Live at

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) — Virtual Investor Conferences, the leading proprietary investor conference series, in partnership with KCSA Strategic Communications (“KCSA”), today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference to be held on April 27-28, 2022. Individual investors, institutional investors, advisors, and analysts are invited to attend this two-day virtual event showcasing live company presentations and interactive discussions focused on psychedelic treatments for mental health disorders.

“As we have seen over the past 18 months, drug development is hard. The good news is many of the companies presenting over the two-day event have shown tremendous clinical progress. I would encourage investors to take a traditional pharma or biotech view of this space and practice patience, do the proper diligence, and the rewards will be tremendous,” said Lewis Goldberg, Managing Partner and Founder of KCSA’s Psychedelics Practice. “Drug development for mental health care takes time, focus, and is capital intensive. The potential returns remain as dramatic as ever, it’s the investors who – to steal a line from Michael Pollan – need to change their minds.”


It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations and schedule 1×1 meetings.

April 27th Agenda:

Time (ET)
Presentation Ticker(s)
9:30 AM HMNC Brain Health Private
10:00 AM Field Trip Health Ltd. NASDAQ: FTRP | TSX: FTRP
10:30 AM Psyched Wellness Ltd. OTCQB: PSYCF | CSE: PSYC
11:00 AM Enveric Biosciences NASDAQ: ENVB
11:30 AM Lobe Sciences Ltd. OTCQB: LOBEF | CSE: LOBE
12:00 PM Ninnion Therapeutics Private
12:30 PM PsyBio Therapeutics OTCQB: PSYBF | TSXV: PSYB
1:00 PM Numinus Wellness OTCQX: NUMIF | TSX: NUMI

April 28th Agenda:

Time (ET)
Presentation Ticker(s)
9:30 AM Small Pharma Inc. OTCQB: DMTTF | TSXV: DMT
10:00 AM Mindset Pharma Inc. OTCQB: MSSTF | CSE: MSET
10:30 AM Gilgamesh Pharma Private
11:00 AM Cybin Inc. NYSE AMEX: CYBN | NEO: CYBN
11:30 AM Filament Health Corp. OTCQB: FLHLF | NEO: FH
12:00 PM Awaken Life Sciences Corp. OTCQB: AWKNF | NEO: AWKN

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit

About Virtual Investor Conferences®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

About KCSA Strategic Communications

KCSA is a fully integrated communications agency specializing in public relations, investor relations and social media, with expertise in financial and professional services, technology, healthcare, digital media and cannabis. Since 1969, the firm has demonstrated strategic thinking and program execution that drives results for its clients in the ever-changing communications and digital landscape. The firm’s clients are its best references. For more information, please visit